Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/CMB stock hub

ASX/CMB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/CMBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.6M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/CMB

In the news

Latest news · ASX/CMB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROEn/a

P25 -118.7P50 -49.4P75 -1.2

ROICn/a

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/CMB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

Groups with data

Currency

AUD

Showing 83 of 83 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000RGS6
Last refreshed	2026-05-10
Market cap	AUD 11.6M
Price	AUD 0.43
Price currency	AUD
Sector	Healthcare
Sic	2836
Symbol	asx/CMB
Website	https://www.cambium.bio

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income Growth Years	0%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	102.48%
EPS Growth Quarters	4
EPS Growth Years	3
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	3.43

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	102.38%
200-day SMA	0.4
50-day SMA	0.49
50-day SMA vs 200-day SMA	50over200
All Time High	1.6
All Time High Change	-73.44%
All Time High Date	2024-04-05
All Time Low	0.19
All Time Low Change	123.68%
All Time Low Date	2025-05-08
ATR	0.03
Beta	-0.15
Beta1y	-1.6
Beta2y	-0.23
Ch YTD	-9.57
High	0.43
High52	0.6
High52 Date	2026-02-03
High52ch	-29.17%
Low	0.43
Low52	0.19
Low52 Date	2025-05-16
Low52ch	123.68%
Ma50ch	-13.11%
Price vs 200-day SMA	5.8%
RSI	46.09
RSI Monthly	41.37
RSI Weekly	45.2
Sharpe ratio	0.37x
Sortino ratio	0.76
Tr YTD	-9.57
Tr1m	3.66%
Tr1w	3.66%
Tr3m	-27.97%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,270,834%
Shares Insiders	13.17%
Shares Out	27,331,918

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	6,839.75x
Ch1m	3.66
Ch1w	3.66
Ch1y	102.4
Ch3m	-27.97
Ch6m	-15
Change	-3.41%
Change From Open	0
Close	0.44
Days Gap	-3.41
Dollar Volume	232.9
F Score	0
Founded	2,013
Is Primary Listing	1
Last Split Date	2024-07-04
Last Split Type	Reverse
Ma150	0.44
Ma150ch	-4.47%
Ma20	0.43
Ma20ch	-1.16%
Open	0.43
Price Date	2026-05-08
Relative Volume	0.08x
Tr6m	-15%
Volume	548

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/CMB pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/CMB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/CMB?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+13.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ASX/CMB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.1

Neutral momentum band

Price vs 200-day MA

+5.8%

50/200-day relationship not available

Beta (5Y)

-0.15

Less volatile than the market

Sharpe ratio

0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/CMB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/CMB stock rating?

asx/CMB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/CMB analysis?

The full report lives at /stocks/asx/CMB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/CMB?

The latest report frames asx/CMB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/CMB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.